Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 7
2021 11
2022 17
2023 20
2024 16
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age.
Lisco G, Disoteo OE, De Tullio A, De Geronimo V, Giagulli VA, Monzani F, Jirillo E, Cozzi R, Guastamacchia E, De Pergola G, Triggiani V. Lisco G, et al. Nutrients. 2023 Dec 25;16(1):63. doi: 10.3390/nu16010063. Nutrients. 2023. PMID: 38201893 Free PMC article. Review.
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study.
Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Lavarra V, Triggiani D, Crudele L, Triggiani V, Sabbà C, De Pergola G, Piazzolla G. Volpe S, et al. Among authors: lisco g. Front Endocrinol (Lausanne). 2023 Sep 13;14:1240263. doi: 10.3389/fendo.2023.1240263. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37780624 Free PMC article.
Endocrine-Disrupting Chemicals: Introduction to the Theme.
Lisco G, Giagulli VA, Iovino M, Guastamacchia E, Pergola G, Triggiani V. Lisco G, et al. Endocr Metab Immune Disord Drug Targets. 2022 Aug 15;22(7):677-685. doi: 10.2174/1871530321666210413124425. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 33847259 Review.
Neuroendocrine Modulation of Food Intake and Eating Behavior.
Iovino M, Messana T, Lisco G, Mariano F, Giagulli VA, Guastamacchia E, De Pergola G, Triggiani V. Iovino M, et al. Among authors: lisco g. Endocr Metab Immune Disord Drug Targets. 2022;22(13):1252-1262. doi: 10.2174/1871530322666220127114326. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35086464 Review.
Covid-19 in Man: A Very Dangerous Affair.
Lisco G, Giagulli VA, De Pergola G, De Tullio A, Guastamacchia E, Triggiani V. Lisco G, et al. Endocr Metab Immune Disord Drug Targets. 2021;21(9):1544-1554. doi: 10.2174/1871530321666210101123801. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33388025 Review.
Bone Disruption and Environmental Pollutants.
Giannattasio R, Lisco G, Giagulli VA, Settembrini S, De Pergola G, Guastamacchia E, Lombardi G, Triggiani V. Giannattasio R, et al. Among authors: lisco g. Endocr Metab Immune Disord Drug Targets. 2022 Aug 15;22(7):704-715. doi: 10.2174/1871530321666210118163538. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 33461478
The neurohypophyseal hormone oxytocin and eating behaviors: a narrative review.
Iovino M, Messana T, Marucci S, Triggiani D, Giagulli VA, Guastamacchia E, Piazzolla G, De Pergola G, Lisco G, Triggiani V. Iovino M, et al. Among authors: lisco g. Hormones (Athens). 2024 Mar;23(1):15-23. doi: 10.1007/s42000-023-00505-y. Epub 2023 Nov 18. Hormones (Athens). 2024. PMID: 37979096 Free PMC article. Review.
Endocrine Disruptors and Obesity: An Overview.
Murro I, Lisco G, Di Noia C, Lampignano L, Zupo R, Giagulli VA, Guastamacchia E, Triggiani V, De Pergola G. Murro I, et al. Among authors: lisco g. Endocr Metab Immune Disord Drug Targets. 2022;22(8):798-806. doi: 10.2174/1871530322666220328122300. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35346017
68 results